News | January 15, 2024
Lupin Life hosted Second Edition of Aptivate Champion Run for Kids
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
The workshop was conducted as a part of the NITI–State workshop series
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Subscribe To Our Newsletter & Stay Updated
